Generic drugs gave Americans access to effective, cheap prescription medications. It’s saved them trillions of dollars over the past few decades. But there are signs this vital industry may be in deep trouble.

After 20 years and $200 billion in revenue, Humira an injectable treatment for autoimmune conditions like rheumatoid arthritis is losing its monopoly.